1. Home
  2. Live Updates
  3. Daniil gataulin

Live Breaking News & Updates on Daniil gataulin

Stay informed with the latest breaking news from Daniil gataulin on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Daniil gataulin and stay connected to the pulse of your community

Ocugen (OCGN) Q4 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2024.

Daniil-gataulin , Swayampakula-ramakanth , Swayampakula-hc-wainwright , Shankar-musunuri , Daniil-gataulin-chardan , Michael-breininger , Tiffany-hamilton-head-of-corporate-communications , Company-analyst , Exchange-commission , Shankar-musunuri-co , Tiffany-hamilton

Ocugen (OCGN) Q4 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2024.

Shankar-musunuri , Swayampakula-ramakanth , Michael-breininger , Swayampakula-hc-wainwright , Daniil-gataulin , Daniil-gataulin-chardan , Exchange-commission , Shankar-musunuri-co , Company-analyst , Tiffany-hamilton-head-of-corporate-communications , Tiffany-hamilton

Ocugen to Participate in Fireside Chat at Chardan's 7th Annual Genetic Medicines Conference

Ocugen to Participate in Fireside Chat at Chardan's 7th Annual Genetic Medicines Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Daniil-gataulin , Shankar-musunuri , Senior-biotech-research-analyst , Head-of-communications , Head-of-clinical-development , Ocugen-inc , Exchange-commission , Linkedin , Twitter , Chief-executive-officer

Ocugen, Inc. (NASDAQ:OCGN) Q2 2023 Earnings Call Transcript

Ocugen, Inc. (NASDAQ:OCGN) Q2 2023 Earnings Call Transcript August 22, 2023 Operator: Good morning and welcome to Ocugen’s second quarter 2023 financial results and business update. Please note that this call is being recorded at this time. All participants’ lines are in listen-only mode. Following the speakers’ commentary, there will be a question and answer […]

Shankar-musunuri , Jennifer-kim , William-ramakanth , Swayampakula-ramakanth , Arun-upadhyay , Robert-leboyer , Daniil-gataulin , Pressmaster-shutterstock , Cantor-fitzgerald , A-nuclear , Exchange-commission

Ocugen (OCGN) Q2 2023 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2023.

Chad , Jen-kim-cantor-fitzgerald , Jennifer-kim , Daniil-gataulin-chardan , William-ramakanth , Arun-upadhyay , Shankar-musunuri , Daniil-gataulin , A-nuclear , Shankar-musunuri-co , Association-for-research , Tiffany-hamilton-head-of-corporate-communications

Kodiak Sciences Faces Downgrade Following Failed GLEAM And GLIMMER Studies - Kodiak Sciences (NASDAQ:KOD)

Chardan Global Insights analyst Daniil Gataulin downgraded the Kodiak Sciences Inc (NASDAQ: KOD) 

Daniil-gataulin , Kodiak-sciences-inckodrating-to , Chardan-global-insights , Kodiak-sciences ,

Ocugen (OCGN) Q1 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2023.

United-states , Americans , Jennifer-kim-cantor-fitzgerald , Quan-vu , Shankar-musunuri , Swayampakula-ramakanth , Jonathan-aschoff , Robert-leboyer , Daniil-gataulin , Jennifer-kim , Daniil-gataulin-chardan , Swayampakula-hc-wainwright

French biotech pulls EMA application for eye disease gene therapy

BioPharma

France , French , Daniil-gataulin , Drug-administration , European-investment-bank , European-medicines-agency , Dive-brief , European-investment , Gene-therapy ,

Ocugen (OCGN) Q4 2022 Earnings Call Transcript

OCGN earnings call for the period ending December 31, 2022.

India , United-states , Americans , Jess-crespo , Quan-vu , Daniil-gataulin , Jennifer-kim , Robert-leboyer , Jessica-crespo , Sean-lee , Daniil-gataulin-chardan , Shankar-musunuri

Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript

OCGN earnings call for the period ending September 30, 2022.

China , Mizuho , Hokkaido , Japan , United-states , India , Chicago , Illinois , Americans , American , Jennifer-kim-cantor-fitzgerald , Jess-crespo